Literature DB >> 2906700

The usefulness of alpha-adrenoceptor blockade in the treatment of hypertension.

J B Warren1, C T Dollery.   

Abstract

The development of selective peripheral alpha 1-adrenoceptor antagonists such as prazosin has produced a valuable class of antihypertensive agents. Side effects of fluid retention and reflex sympathetic stimulation usually limit these agents to third-line therapy but their combination with a beta-receptor antagonist and a diuretic provides a powerful regimen. Alpha-adrenoceptor antagonists are useful in patients with conditions such as gout, diabetes or bronchospasm which preclude the use of other agents. Although many new drugs are being developed, little information is available yet on the long-term outcome of therapy with this class of drugs for patients with hypertension.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2906700

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  9 in total

Review 1.  Selective alpha 1-adrenoreceptor blockers in the treatment of hypertension: should we be using them more?

Authors:  M Ligueros; R Unwin; M Wilkins
Journal:  Clin Auton Res       Date:  1991-09       Impact factor: 4.435

Review 2.  Convergence of therapy-induced senescence (TIS) and EMT in multistep carcinogenesis: current opinions and emerging perspectives.

Authors:  Mir Mohd Faheem; Nathan D Seligson; Syed Mudabir Ahmad; Reyaz Ur Rasool; Sumit G Gandhi; Madhulika Bhagat; Anindya Goswami
Journal:  Cell Death Discov       Date:  2020-06-15

Review 3.  Inside the hypoxic tumour: reprogramming of the DDR and radioresistance.

Authors:  Katheryn Begg; Mahvash Tavassoli
Journal:  Cell Death Discov       Date:  2020-08-18

Review 4.  The Ku complex: recent advances and emerging roles outside of non-homologous end-joining.

Authors:  Sanna Abbasi; Gursimran Parmar; Rachel D Kelly; Nileeka Balasuriya; Caroline Schild-Poulter
Journal:  Cell Mol Life Sci       Date:  2021-04-15       Impact factor: 9.261

Review 5.  Treatment landscape of triple-negative breast cancer - expanded options, evolving needs.

Authors:  Giampaolo Bianchini; Carmine De Angelis; Luca Licata; Luca Gianni
Journal:  Nat Rev Clin Oncol       Date:  2021-11-09       Impact factor: 66.675

6.  Combined deletions of IHH and NHEJ1 cause chondrodystrophy and embryonic lethality in the Creeper chicken.

Authors:  Keiji Kinoshita; Takayuki Suzuki; Manabu Koike; Chizuko Nishida; Aki Koike; Mitsuo Nunome; Takeo Uemura; Kenji Ichiyanagi; Yoichi Matsuda
Journal:  Commun Biol       Date:  2020-03-25

7.  Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer.

Authors:  Amila Suraweera; Alex Duff; Mark N Adams; Christian Jekimovs; Pascal H G Duijf; Cheng Liu; Matthew McTaggart; Sam Beard; Kenneth J O'Byrne; Derek J Richard
Journal:  Br J Cancer       Date:  2020-05-22       Impact factor: 7.640

8.  The X-linked trichothiodystrophy-causing gene RNF113A links the spliceosome to cell survival upon DNA damage.

Authors:  Kateryna Shostak; Zheshen Jiang; Benoit Charloteaux; Alice Mayer; Yvette Habraken; Lars Tharun; Sebastian Klein; Xinyi Xu; Hong Quan Duong; Andrii Vislovukh; Pierre Close; Alexandra Florin; Florian Rambow; Jean-Christophe Marine; Reinhard Büttner; Alain Chariot
Journal:  Nat Commun       Date:  2020-03-09       Impact factor: 14.919

9.  Conditioning attenuates kidney and heart injury in rats following transient suprarenal occlusion of the abdominal aorta.

Authors:  Dimitra M Karageorgiadi; Diamantis I Tsilimigras; Platonas Selemenakis; Vassiliki Vlachou; Anne-Lise de Lastic; Maria Rodi; Danai Chatziathanasiou; Konstantinos Savvatakis; Nikolaos Antoniou; Aikaterini C Deli; Alexandros Papalampros; Konstantinos A Filis; Athanasia Mouzaki; Anastasia Varvarigou; George Zografos; Vassilis G Gorgoulis; Ioannis S Pateras; Fragiska Sigala
Journal:  Sci Rep       Date:  2020-03-19       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.